Vancomycin trough concentration in adult patients with periprosthetic joint infection: A machine learning‐based covariate model
British Journal of Clinical Pharmacology · 2024
DOI: 10.1111/bcp.16112 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Clinical Pharmacology, 2024. Verfasst von Yue-Wen Chen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China. Hauptthemen laut MEDLINE: Vancomycin, Anti-Bacterial Agents, Machine Learning, Prosthesis-Related Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Joint Funds for the Innovation of Science and Technology, Fujian Province, Fujian Provincial Health Technology Project.
Abstract (Originalsprache)
Aims
Although there are various model‐based approaches to individualized vancomycin (VCM) administration, few have been reported for adult patients with periprosthetic joint infection (PJI). This work attempted to develop a machine learning (ML)‐based model for predicting VCM trough concentration in adult PJI patients.
Methods
The dataset of 287 VCM trough concentrations from 130 adult PJI patients was split into a training set (229) and a testing set (58) at a ratio of 8:2, and an independent external 32 concentrations were collected as a validation set. A total of 13 covariates and the target variable (VCM trough concentration) were included in the dataset. A covariate model was respectively constructed by support vector regression, random forest regression and gradient boosted regression trees and interpreted by SHapley Additive exPlanation (SHAP).
Results
The SHAP plots visualized the weight of the covariates in the models, with estimated glomerular filtration rate and VCM daily dose as the 2 most important factors, which were adopted for the model construction. Random forest regression was the optimal ML algorithm with a relative accuracy of 82.8% and absolute accuracy of 67.2% ( R 2 =.61, mean absolute error = 2.4, mean square error = 10.1), and its prediction performance was verified in the validation set.
Conclusion
The proposed ML‐based model can satisfactorily predict the VCM trough concentration in adult PJI patients. Its construction can be facilitated with only 2 clinical parameters (estimated glomerular filtration rate and VCM daily dose), and prediction accuracy can be rationalized by SHAP values, which highlights a profound practical value for clinical dosing guidance and timely treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
- Department of Pharmacy, National Regional Medical Center, Binhai Campus of The First Affiliated Hospital, Fujian Medical University, Fuzhou, China.
- School of Mechanical Engineering and Automation, Fuzhou University, Fuzhou, China.
ORCID-Profile: Zhou-Jie Liu
Förderung
- Joint Funds for the Innovation of Science and Technology, Fujian Province
- Fujian Provincial Health Technology Project
Zitieren
APA
Chen, Y. W., Lin, X. K., Huang, C., Wu, W., Lin, W. W., Chen, S., Lu, Z. X., You, Y. Y., & Liu, Z. J. (2024). Vancomycin trough concentration in adult patients with periprosthetic joint infection: A machine learning‐based covariate model. British Journal of Clinical Pharmacology. https://doi.org/10.1111/bcp.16112
Vancouver
Chen YW, Lin XK, Huang C, Wu W, Lin WW, Chen S, et al. Vancomycin trough concentration in adult patients with periprosthetic joint infection: A machine learning‐based covariate model. British Journal of Clinical Pharmacology. 2024. doi:10.1111/bcp.16112
BibTeX
@article{Chen2024,
author = {Chen, Yue-Wen and Lin, Xi-Kai and Huang, Chen and Wu, Wei and Lin, Wei-Wei and Chen, Si and Lu, Zong-Xing and You, Ya-Yi and Liu, Zhou-Jie},
title = {Vancomycin trough concentration in adult patients with periprosthetic joint infection: A machine learning‐based covariate model},
journal = {British Journal of Clinical Pharmacology},
year = {2024},
doi = {10.1111/bcp.16112}
}
EUVIMED